Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.51 |
| ▸ | HTR7 | P34969 | 3/20 | 0.49 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30270468 | 0.82 | ALDH1A1 (0.64) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 | |
| SCHEMBL26212898 | 0.82 | ALDH1A1 (0.64) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 | |
| SCHEMBL6290158 | 0.77 | ALDH1A1 (0.66) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 | |
| SCHEMBL16053212 | 0.76 | ALDH1A1 (0.67) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 | |
| SCHEMBL25759592 | 0.76 | ALDH1A1 (0.64) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 | |
| SCHEMBL30390015 | 0.76 | ALDH1A1 (0.64) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 | |
| SCHEMBL6008517 | 0.76 | ALDH1A1 (0.64) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 | |
| SCHEMBL6370836 | 0.76 | ALDH1A1 (0.64) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 | |
| SCHEMBL3687222 | 0.76 | ALDH1A1 (0.65) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 | |
| SCHEMBL3685286 | 0.74 | ALDH1A1 (0.68) | ALDH1A1LMNAGAASMN1; SMN2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127228-A1 | METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT | SOOCHOW UNIVERSITY (CN) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127228-A1 | METHOD FOR PRODUCING DICHLORO ADDITION PRODUCT OF ALIPHATIC OLEFIN BY PHOTOCATALYSIS UNDER VISIBLE LIGHT | AOC1, AOC2, AOC3 | ALDH1A1 31/4885LMNA 3716/4885GAA 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.